Will RG et al. 1996, A new variant of Creutzfeldt-Jakob disease in the UK (Lancet 347:921-925)

This is the paper in which the UK national CJD surveillance team first described what became known as variant CJD (vCJD). Ten UK cases with a distinct neuropathological profile, young age and atypical clinical features were reported, with none found in the parallel European surveillance studies, and the authors judged a link to BSE plausible but not provable from their data. The citation was checked against Europe PMC and PubMed: Lancet 6 April 1996, volume 347, issue 9006, pages 921 to 925. Only aggregate findings are recorded here; the full text was not opened. Information only.

Key facts

  • Citation as verified: ten authors led by R. G. Will of the National CJD Surveillance Unit, Western General Hospital, Edinburgh; Lancet 1996;347(9006):921-925; DOI 10.1016/s0140-6736(96)91412-9; PMID 8598754.
  • The scout's proposal reason is accurate on authorship, journal, year, volume and pages. The record also supplies the issue number (9006) and the exact date (6 April 1996), which the proposal lacked.
  • The paper rests on surveillance that was reinstated in the UK in 1990 to detect any change in CJD after the BSE epidemic in cattle.
  • Cases were found mainly through referral by neurologists and neuropathologists and through death certificates; relatives completed a risk-factor questionnaire, and about 70 percent of suspect cases had a neuropathological examination.
  • Comparable studies in France, Germany, Italy and the Netherlands ran from 1993 to 1995 and found no similar cases, which is why the authors called the pattern possibly unique to the UK.
  • Ten UK cases showed a new neuropathological profile, unusually young age, atypical clinical findings and absence of the typical EEG features of CJD.
  • The authors proposed a new variant of CJD and called a BSE link plausible, but said it could not be confirmed from this evidence alone.
  • The same issue carried a commentary by Collinge and Rossor, and PubMed lists six other linked comments, including a French report of a further variant case.
  • Later public-health summaries confirm the paper's direction: vCJD is now treated as linked to BSE exposure, tends to affect younger people (median age about 28 years) and runs about 13 to 14 months, against about 68 years and 4 to 5 months for classic CJD.
  • Later case counts in public sources differ by date: ECDC (2013 to 2015 data) gives 229 cases from 11 countries, 177 of them in the UK, and a WHO page cites over 140 UK cases; these are not the 1996 figures.

Timeline

  1. 1990UK CJD surveillance reinstated to monitor for change after the cattle BSE epidemic.
  2. 1993to 1995 Parallel CJD surveillance studies run in France, Germany, Italy and the Netherlands, forming the comparison group.
  3. 1996vCJD identified when ten cases of a new disease were notified in the UK (ECDC wording).
  4. 1996Paper published in The Lancet, issue 9006.
  5. 2000EU vCJD surveillance made mandatory under Commission Decision 2000/96/EC.
  6. 2007EuroCJD network moved under ECDC responsibility, with coordination from the Edinburgh unit.

Last checked 1 November 2026

Sources for this page